Pharmaceutical companies Sanofi and GlaxoSmithKline have also teamed up with the hope of making a vaccine available by the middle of next year. Their vaccine is in the phase two stage, where the vaccine is given to hundreds of people so scientists can learn more about its safety and correct dosage, and phase three is planned by the end of the year.